RxDoctor Payments Data

Betty Falecki, NP

Family · Port Huron, MINPI 1427666056

Payments from drug & device makers

$2,389in general payments, 2019–2025

Across 134 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$286
  • Novartis$154
  • Bayer$150
  • Otsuka America Pharmaceutical, Inc.$145
  • AbbVie$143
  • Merck$120
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$2,389100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,389 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$28,018
Medicare patients
91
Services billed
587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide49$59,505
OzempicSemaglutide28$36,014
MounjaroTirzepatide34$34,335
VraylarCariprazine Hcl16$23,120
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$22,930
JardianceEmpagliflozin13$12,397
LinzessLinaclotide11$8,760
EliquisApixaban15$8,303
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl34$7,288
Albuterol Sulfate HfaAlbuterol Sulfate173$6,151
BrilintaTicagrelor12$5,331
SymbicortBudesonide/Formoterol Fumarate23$5,028
DuleraMometasone/Formoterol11$3,529
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen163$1,716
Atorvastatin Calcium163$1,631

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$56$93,83983 claims
Novo NordiskOzempic$108$36,01428 claims
AbbVieVraylar, Linzess$143$31,88027 claims
GSKTrelegy Ellipta$116$22,93035 claims
Boehringer IngelheimJardiance$68$12,39713 claims
AstraZenecaBrilinta, Symbicort$99$10,36035 claims
PfizerEliquis$73$8,30315 claims
MerckDulera$120$3,52911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →